Dr. Savoldo is a physician/scientist with training in hematology and cancer immunology.
Education and Training
PhD, Baylor College of Medicine
MD, University of Parma, Italy
Fellowship, Hematology, University of Parma, Italy
Research
Dr. Savoldo is interested in the gene modification of T-cells to redirect them to tumors by transgenic expression of alpha-betaTCRs or of chimeric tumor-specific receptors (CARs), in particular for hematological malignancies such as CD19+ leukemia/lymphomas and CD30+ Hodgkin’s lymphoma.